BCWORLD PHARM. Co. Ltd (200780) — Capital Reinvestment Ratio
BCWORLD PHARM. Co. Ltd (200780) has a Capital Reinvestment Ratio of 1.14x as of September 2025, meaning it reinvests 1% of its operating cash flow (₩1.43 Billion) in capital expenditures (₩1.63 Billion). Check BCWORLD PHARM. Co. Ltd tangible equity quality to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
BCWORLD PHARM. Co. Ltd Capital Reinvestment Ratio (2015–2024)
This chart tracks BCWORLD PHARM. Co. Ltd's Capital Reinvestment Ratio across 8 annual periods. For the full cash flow conversion analysis, see BCWORLD PHARM. Co. Ltd (200780) cash conversion ratio.
Annual Capital Reinvestment Ratio for BCWORLD PHARM. Co. Ltd (2015–2024)
Year-by-year Capital Reinvestment Ratio for BCWORLD PHARM. Co. Ltd from 2015 to 2024. See 200780 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.60x | ₩4.04 Billion | ₩2.41 Billion | ▲ +140.5% |
| 2023 | 0.25x | ₩10.94 Billion | ₩2.71 Billion | ▼ -72.6% |
| 2022 | 0.90x | ₩6.88 Billion | ₩6.22 Billion | ▼ -48.7% |
| 2019 | 1.76x | ₩12.11 Billion | ₩21.32 Billion | ▼ -68.6% |
| 2018 | 5.60x | ₩5.34 Billion | ₩29.92 Billion | ▲ +167.0% |
| 2017 | 2.10x | ₩7.90 Billion | ₩16.58 Billion | ▼ -95.9% |
| 2016 | 51.55x | ₩243.66 Million | ₩12.56 Billion | ▲ +1692.4% |
| 2015 | 2.88x | ₩8.78 Billion | ₩25.26 Billion | — |